Lung Cancer News and Research

Latest Lung Cancer News and Research

A cell's energy level is critical to its survival

In an ongoing effort to fight disease by manipulating energy regulation of cells, a collaborative study led by Dartmouth Medical School (DMS) has demonstrated that cells lacking a tumor-suppressing kinase called LKB1 can still maintain healthy energy levels when they become stressed.

22 Aug 2005

Mutations in the targets of designer drugs critically influence their effectiveness

Two designer cancer drugs differed dramatically in a laboratory test comparing their ability to shut down a mutant, overactive growth signal in lung cancer cells, reports a team headed by scientists at the Dana-Farber Cancer Institute.

18 Aug 2005

Lung cancer cure possible with early screening

Recent reports in the media of the deaths of well known people from lung cancer and the surprising news that Dana Reeve, the non-smoking wife of the late Christopher Reeve has the disease, has re-ignited concerns about the so-called 'silent killer', lung cancer.

15 Aug 2005

Introgen announces additional broad patent in China

Introgen Therapeutics has announced that a patent with broad claims directed to combination therapy with the p53 gene and conventional chemotherapy or radiation was issued in China.

11 Aug 2005

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

By the time the human genome was mapped, cancer researchers had already begun investigating the proteins that were encoded by these newly identified genes.

9 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Tobacco industry is continuing its targeted marketing to teens via candy-flavored cigarettes

Advertising and promotion for these products uses hip-hop imagery, attractive women, and other imagery to appeal to youth in similar ways that Joe Camel did a decade ago.

2 Aug 2005

Amazing 'smart bomb' drug zaps cancer cells in mice without damaging healthy cells

Scientists say they have developed an anti-cancer 'bomb' which has a similar behavior to a Trojan horse.

28 Jul 2005

Cancer biology, pharmacology and engineering combine to create cancer smart bomb

Imagine a cancer drug that can burrow into a tumor, seal the exits and detonate a lethal dose of anti-cancer toxins, all while leaving healthy cells unscathed.

27 Jul 2005

Government in Ontario will pay for three new cancer drugs

Canadian Health Minister George Smitherman has announced that the government will add three new and expensive cancer-fighting drugs to the list of medications it funds.

25 Jul 2005

British scientist who discovered link with smoking and cancer, dies at 92

The British scientist Sir Richard Doll, who was the first scientist to expose the link between smoking and lung cancer, has died in hospital, after a short illness; he was 92.

25 Jul 2005

Male lung cancer deaths are now falling in most EU countries

Among men, lung cancer deaths are now falling in most EU countries, including all new member states from central and eastern Europe, but they are still rising among women, find researchers in this week’s BMJ.

21 Jul 2005

Quit smoking to heal that gum disease and live longer!

According to a new study, smokers are at least 6 times more likely to develop gum disease than non-smokers.

19 Jul 2005

PGE2 may be a target for Celebrex therapy

A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.

17 Jul 2005

Novel treatment for ovarian cancer

The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States.

15 Jul 2005

Asbestos in rocks cause lung cancer

According to a study by a team at UC Davis Department of Public Health Sciences, everyday exposure to naturally occurring asbestos, increases the risk of developing malignant mesothelioma.

14 Jul 2005

Erlotinib increases survival in patients with advanced non-small cell lung cancer

An international clinical study led by Canadian researchers has demonstrated that a drug called erlotinib increases survival in patients with advanced non-small cell lung cancer who typically have no other treatment options.

13 Jul 2005

Mesothelioma may be caused by exposure to ultramafic rock

Everyday exposure to naturally occurring asbestos increases the risk of developing malignant mesothelioma, according to a study by UC Davis researchers.

13 Jul 2005

Female lung cancer in Europe rising

The first comprehensive picture of female lung cancer mortality trends in Europe shows rates are still rising in most countries. But, the research does indicate that there is some room for cautious optimism in the longer term due to decreases or smaller rates of increase in some countries and a more favourable trend among younger women in many countries.

13 Jul 2005

Many local health directors unsure of authority to curtail smoking

Local health department directors across North Carolina are confused about state laws covering whether their facilities can be made smoke-free, but still strongly support such policies, according to a new University of North Carolina at Chapel Hill study.

11 Jul 2005